Arabic Arabic English English French French German German
dark

AstraZeneca Vaccine Collaborator Vaccitech Snares $110.5 Million IPO

After quietly filing plans for an initial public offering earlier this month, U.K.-based Vaccitech raised $110.5 million in its IPO. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

CareCar Raises $3M to Expand Tech-enabled Benefit Manager Platform

Next Post

KIYATEC Announces Investment from Seae Ventures and Names Co-founder and Managing Partner Jason Robart to its Board of Directors

Related Posts
Total
0
Share